Literature DB >> 17046589

Identification of differentially expressed genes in the high and low metastatic human ovarian cancer cell lines and analyses of their chromosomal localizations and functions.

Shen-Hua Xu1, Han-Zhou Mu, Lin-Hui Gu, Chi-Hong Zhu, Xiang-Lin Liu.   

Abstract

Oligonucleotide microarrays were used to study the differences of gene expressions in high (H) and low (L) metastatic ovarian cancer cell lines and in normal ovarian tissues (C). Bioinformatics was used to identify novel genes and their functions as well as chromosomal localizations. A total of 409 genes were differentially expressed between the high and low metastatic ovarian cancer cell lines. Of them, 271 genes were up regulated (Signal Log Ratio[SLR] > or = 1), and 138 genes were down regulated (SLR < or = -1). Except one gene whose location was unknown, all these genes were localized randomly on all the chromosomes, with a majority of them localized to Chromosomes 1, 6, 2, 17, 3, 5 and 11. Chromosome 1 contained, 43 of them (10.7%), the most for a single chromosome. A total of 264 genes (64.7%) were localized on the short arm of the chromosome (q). Functional classification showed that the 104 (25.4%) genes coding for enzymes and enzyme regulators made up the largest functional group, followed by signal transduction activity genes (43, 10.5%), nucleic acid binding activity genes (42, 10.3%), and proteins binding activity genes (34, 8.3%). These four groups accounted for 54.5% of all the differentially expressed genes. In addition, the functions of 76 genes (18.6%) were unknown. Tumor metastasis is the result of a number of genes acting in concert. The four functional groups of genes classified among these genes and their abnormalities would be the focus of further studies on ovarian cancer metastasis.

Entities:  

Mesh:

Year:  2006        PMID: 17046589     DOI: 10.1016/S0379-4172(06)60123-6

Source DB:  PubMed          Journal:  Yi Chuan Xue Bao        ISSN: 0379-4172


  3 in total

1.  Identification and chromosomal localizations of signal transduction genes associated with human ovarian cancer metastasis.

Authors:  Zhu Xin; Xu Shenhua; Mou Hanzhou; Gu Linhui; Zhu Chihong; Liu Xianglin
Journal:  Med Oncol       Date:  2012-02-05       Impact factor: 3.064

2.  ADP-ribosylation factor-like 4C (ARL4C), a novel ovarian cancer metastasis suppressor, identified by integrated genomics.

Authors:  Dan Su; Dionyssios Katsaros; Shenhua Xu; Haiyan Xu; Yun Gao; Nicoletta Biglia; Jianguo Feng; Lisha Ying; Ping Zhang; Chiara Benedetto; Herbert Yu
Journal:  Am J Transl Res       Date:  2015-02-15       Impact factor: 4.060

3.  Complement component 7 (C7), a potential tumor suppressor, is correlated with tumor progression and prognosis.

Authors:  Lisha Ying; Fanrong Zhang; Xiaodan Pan; Kaiyan Chen; Nan Zhang; Jiaoyue Jin; Junzhou Wu; Jianguo Feng; Herbert Yu; Hongchuan Jin; Dan Su
Journal:  Oncotarget       Date:  2016-12-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.